|
|
regionalization
|
GO:0003002 |
337 |
0.600
|
|
|
|
positive regulation of smoothened signaling pathway
|
GO:0045880 |
23 |
0.546
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.440
|
|
|
|
skeletal muscle satellite cell differentiation
|
GO:0014816 |
6 |
0.394
|
|
|
|
roof plate formation
|
GO:0021509 |
1 |
0.323
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.312
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.268
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.258
|
|
|
|
forebrain regionalization
|
GO:0021871 |
25 |
0.246
|
|
|
|
floor plate formation
|
GO:0021508 |
2 |
0.229
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.211
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.199
|
|
|
|
smoothened signaling pathway involved in ventral spinal cord patterning
|
GO:0021910 |
7 |
0.199
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.187
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.174
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.168
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.164
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.158
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.157
|
|
|
|
floor plate morphogenesis
|
GO:0033505 |
3 |
0.155
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.148
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.145
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.142
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.139
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.139
|
|
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
35 |
0.139
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.137
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.130
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.122
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.117
|
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.110
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.110
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.106
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.105
|
|
|
|
astrocyte activation
|
GO:0048143 |
2 |
0.103
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.103
|
|
|
|
positive regulation of hh target transcription factor activity
|
GO:0007228 |
3 |
0.102
|
|
|
|
anterior commissure morphogenesis
|
GO:0021960 |
6 |
0.101
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.100
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.099
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.098
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.097
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.092
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.092
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.089
|
|
|
|
dorsal ventral neural tube patterning
|
GO:0021904 |
28 |
0.088
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.087
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.086
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.086
|
|
|
|
midbrain hindbrain boundary morphogenesis
|
GO:0021555 |
4 |
0.086
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.084
|
|
|
|
smoothened signaling pathway involved in dorsal ventral neural tube patterning
|
GO:0060831 |
12 |
0.083
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.081
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.081
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.080
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.078
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.077
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.075
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.074
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.070
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.067
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.066
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.066
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.065
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.065
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.063
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.062
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.062
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.062
|
|
|
|
cerebral cortex radial glia guided migration
|
GO:0021801 |
17 |
0.062
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.061
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.061
|
|
|
|
signal transduction downstream of smoothened
|
GO:0007227 |
4 |
0.060
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.059
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.059
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.058
|
|
|
|
forebrain radial glial cell differentiation
|
GO:0021861 |
4 |
0.058
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.058
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.057
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.056
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.056
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.055
|
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.054
|
|
|
|
myoblast migration
|
GO:0051451 |
8 |
0.053
|
|
|
|
somatic sex determination
|
GO:0018993 |
2 |
0.052
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.052
|
|
|
|
axial mesodermal cell fate commitment
|
GO:0048322 |
1 |
0.051
|
|
|
|
embryonic nail plate morphogenesis
|
GO:0035880 |
3 |
0.051
|
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.050
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.049
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.049
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.049
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.049
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.048
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.048
|
|
|
|
mesenchymal cell proliferation involved in ureter development
|
GO:0072198 |
4 |
0.048
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.047
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.046
|
|
|
|
cellular response to cholesterol
|
GO:0071397 |
2 |
0.046
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.046
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.046
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.045
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.044
|
|
|
|
oligodendrocyte development
|
GO:0014003 |
20 |
0.043
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.043
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.043
|
|
|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
0.042
|
|
|
|
embryonic neurocranium morphogenesis
|
GO:0048702 |
3 |
0.042
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.042
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.040
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.040
|
|
|
|
activation of meiosis
|
GO:0090427 |
4 |
0.040
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.039
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.038
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.038
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.038
|
|
|
|
forebrain anterior posterior pattern specification
|
GO:0021797 |
5 |
0.038
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.037
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.037
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.036
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.036
|
|
|
|
carbon catabolite regulation of transcription
|
GO:0045990 |
4 |
0.036
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.036
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.036
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.035
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.035
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.035
|
|
|
|
spinal cord ventral commissure morphogenesis
|
GO:0021965 |
2 |
0.035
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.035
|
|
|
|
metanephric mesenchymal cell proliferation involved in metanephros development
|
GO:0072136 |
2 |
0.034
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.034
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.034
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.034
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.033
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.033
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.033
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.033
|
|
|
|
ventral midline development
|
GO:0007418 |
4 |
0.032
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.032
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.032
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.032
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.032
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.032
|
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
2 |
0.032
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.032
|
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.031
|
|
|
|
neural plate development
|
GO:0001840 |
12 |
0.031
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.031
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.031
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.031
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.030
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000433 |
1 |
0.030
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.030
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.029
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.029
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.029
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.029
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.029
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.029
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.029
|
|
|
|
negative regulation of notch signaling pathway
|
GO:0045746 |
14 |
0.028
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.028
|
|
|
|
metanephric capsule specification
|
GO:0072267 |
1 |
0.028
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.028
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.028
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.028
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.028
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.028
|
|
|
|
central nervous system projection neuron axonogenesis
|
GO:0021952 |
21 |
0.027
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.027
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.027
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.027
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.027
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.027
|
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.027
|
|
|
|
regulation of tendon cell differentiation
|
GO:2001049 |
1 |
0.027
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.026
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.026
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.026
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.026
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.026
|
|
|
|
determination of left right asymmetry in nervous system
|
GO:0035545 |
1 |
0.026
|
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.026
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.026
|
|
|
|
female somatic sex determination
|
GO:0019101 |
1 |
0.026
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.026
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.026
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.025
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.025
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.025
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.025
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.025
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.025
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.025
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.025
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.025
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.025
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.024
|
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
42 |
0.024
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.024
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.024
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.024
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.024
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.024
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.024
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.023
|
|
|
|
ventral spinal cord interneuron specification
|
GO:0021521 |
11 |
0.023
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.023
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.023
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.023
|
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
26 |
0.023
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.023
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.023
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.023
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.023
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.023
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.022
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.022
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.022
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.022
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.022
|
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.022
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.022
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.022
|
|
|
|
negative regulation of dna binding
|
GO:0043392 |
20 |
0.022
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.022
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.022
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.022
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.021
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.021
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.021
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.021
|
|
|
|
otic placode formation
|
GO:0043049 |
1 |
0.021
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.021
|
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.021
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.021
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.021
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.021
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.021
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.021
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.020
|
|
|
|
exocrine pancreas development
|
GO:0031017 |
7 |
0.020
|
|
|
|
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation
|
GO:0021938 |
4 |
0.020
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.020
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.020
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.020
|
|
|
|
osteoblast development
|
GO:0002076 |
17 |
0.020
|
|
|
|
eye photoreceptor cell fate commitment
|
GO:0042706 |
2 |
0.020
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.020
|
|
|
|
regulation of rhodopsin gene expression
|
GO:0007468 |
3 |
0.020
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.020
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.020
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.020
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.019
|
|
|
|
regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902256 |
2 |
0.019
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.019
|
|
|
|
mammary gland specification
|
GO:0060594 |
4 |
0.019
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.019
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.019
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.019
|
|
|
|
transcription from rna polymerase i promoter
|
GO:0006360 |
13 |
0.019
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.019
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.019
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.019
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.019
|
|
|
|
cranial nerve formation
|
GO:0021603 |
4 |
0.019
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.019
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.019
|
|
|
|
negative regulation of branching involved in ureteric bud morphogenesis
|
GO:0090191 |
4 |
0.019
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.019
|
|
|
|
protein stabilization
|
GO:0050821 |
25 |
0.018
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.018
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.018
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.018
|
|
|
|
female sex determination
|
GO:0030237 |
1 |
0.018
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.018
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.018
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.018
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.018
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.018
|
|
|
|
nail development
|
GO:0035878 |
5 |
0.018
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.018
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.018
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.018
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.018
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.018
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.018
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.018
|
|
|
|
positive regulation of mesenchymal cell proliferation involved in ureter development
|
GO:2000729 |
3 |
0.017
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.017
|
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.017
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.017
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.017
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.017
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.017
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.017
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.017
|
|
|
|
embryonic retina morphogenesis in camera type eye
|
GO:0060059 |
7 |
0.017
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.017
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.017
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.017
|
|
|
|
carbon catabolite regulation of transcription from rna polymerase ii promoter
|
GO:0000429 |
4 |
0.017
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.017
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.017
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.017
|
|
|
|
trigeminal ganglion development
|
GO:0061551 |
5 |
0.017
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.017
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.017
|
|
|
|
cellular response to estrogen stimulus
|
GO:0071391 |
12 |
0.017
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.017
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.017
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.017
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.017
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.016
|
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.016
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.016
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.016
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.016
|
|
|
|
cellular response to sterol
|
GO:0036315 |
2 |
0.016
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.016
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.016
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.016
|
|
|
|
regulation of mesenchymal cell proliferation involved in ureter development
|
GO:0072199 |
3 |
0.016
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.016
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.016
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.016
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.016
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.016
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.016
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.016
|
|
|
|
cellular response to alcohol
|
GO:0097306 |
23 |
0.016
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.016
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.016
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.015
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.015
|
|
|
|
embryonic skeletal joint morphogenesis
|
GO:0060272 |
11 |
0.015
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.015
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.015
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.015
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.015
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.015
|
|
|
|
anterior semicircular canal development
|
GO:0060873 |
1 |
0.015
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.015
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.015
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.015
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.015
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.015
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.015
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.015
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.015
|
|
|
|
spinal cord dorsal ventral patterning
|
GO:0021513 |
23 |
0.015
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.015
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.015
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.015
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.015
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.015
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.015
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.015
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.014
|
|
|
|
regulation of t cell differentiation in thymus
|
GO:0033081 |
24 |
0.014
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.014
|
|
|
|
regulation of protein heterodimerization activity
|
GO:0043497 |
2 |
0.014
|
|
|
|
positive regulation of vascular wound healing
|
GO:0035470 |
1 |
0.014
|
|
|
|
3 utr mediated mrna stabilization
|
GO:0070935 |
2 |
0.014
|
|
|
|
embryonic genitalia morphogenesis
|
GO:0030538 |
4 |
0.014
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.014
|
|
|
|
activin receptor signaling pathway
|
GO:0032924 |
18 |
0.014
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.014
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.014
|
|
|
|
corticotropin hormone secreting cell differentiation
|
GO:0060128 |
3 |
0.014
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.014
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.014
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.014
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.014
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.014
|
|
|
|
regulation of somitogenesis
|
GO:0014807 |
6 |
0.014
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.014
|
|
|
|
positive regulation of myoblast differentiation
|
GO:0045663 |
8 |
0.014
|
|
|
|
regulation of receptor binding
|
GO:1900120 |
4 |
0.014
|
|
|
|
epithelial mesenchymal signaling involved in prostate gland development
|
GO:0060738 |
2 |
0.014
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.014
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.014
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.014
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.013
|
|
|
|
cerebellar purkinje cell differentiation
|
GO:0021702 |
13 |
0.013
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.013
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.013
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.013
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.013
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.013
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.013
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.013
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.013
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.013
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.013
|
|
|
|
otolith morphogenesis
|
GO:0032474 |
3 |
0.013
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.013
|
|
|
|
thermosensory behavior
|
GO:0040040 |
1 |
0.013
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.013
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.013
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.013
|
|
|
|
embryonic skeletal joint development
|
GO:0072498 |
13 |
0.013
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.013
|
|
|
|
thalamus development
|
GO:0021794 |
11 |
0.013
|
|
|
|
central nervous system neuron axonogenesis
|
GO:0021955 |
28 |
0.013
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.013
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.013
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.013
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.013
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.013
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.013
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.013
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.013
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.012
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.012
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.012
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.012
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.012
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.012
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
16 |
0.012
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.012
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.012
|
|
|
|
epiboly involved in wound healing
|
GO:0090505 |
8 |
0.012
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.012
|
|
|
|
negative regulation of muscle tissue development
|
GO:1901862 |
20 |
0.012
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.012
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.012
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.012
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.012
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.012
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.012
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.012
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.012
|
|
|
|
lateral sprouting from an epithelium
|
GO:0060601 |
13 |
0.012
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.012
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.012
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.012
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.012
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.012
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.012
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.012
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.012
|
|
|
|
axial mesodermal cell differentiation
|
GO:0048321 |
1 |
0.012
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.012
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.012
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.012
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.012
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.012
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.012
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.012
|
|
|
|
metanephric capsule formation
|
GO:0072266 |
1 |
0.012
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.012
|
|
|
|
subpallium development
|
GO:0021544 |
20 |
0.012
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.012
|
|
|
|
forebrain morphogenesis
|
GO:0048853 |
17 |
0.012
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.012
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.012
|
|
|
|
regulation of cerebellar granule cell precursor proliferation
|
GO:0021936 |
12 |
0.012
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
30 |
0.011
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.011
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.011
|
|
|
|
photoreceptor cell fate commitment
|
GO:0046552 |
2 |
0.011
|
|
|
|
negative regulation of transcription by glucose
|
GO:0045014 |
1 |
0.011
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.011
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.011
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.011
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.011
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.011
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.011
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.011
|
|
|
|
pattern specification involved in metanephros development
|
GO:0072268 |
4 |
0.011
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.011
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.011
|
|
|
|
positive regulation of dna endoreduplication
|
GO:0032877 |
2 |
0.011
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.011
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.011
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.011
|
|
|
|
kidney mesenchymal cell proliferation
|
GO:0072135 |
2 |
0.011
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.011
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.011
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.011
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.011
|
|
|
|
homeostasis of number of cells within a tissue
|
GO:0048873 |
25 |
0.011
|
|
|
|
frontal suture morphogenesis
|
GO:0060364 |
2 |
0.011
|
|
